Publication:
Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.

dc.contributor.authorSchnitzler, Alfons
dc.contributor.authorMir, Pablo
dc.contributor.authorBrodsky, Matthew A
dc.contributor.authorVerhagen, Leonard
dc.contributor.authorGroppa, Sergiu
dc.contributor.authorAlvarez, Ramiro
dc.contributor.authorEvans, Andrew
dc.contributor.authorBlazquez, Marta
dc.contributor.authorNagel, Sean
dc.contributor.authorPilitsis, Julie G
dc.contributor.authorPötter-Nerger, Monika
dc.contributor.authorTse, Winona
dc.contributor.authorAlmeida, Leonardo
dc.contributor.authorTomycz, Nestor
dc.contributor.authorJimenez-Shahed, Joohi
dc.contributor.authorLibionka, Witold
dc.contributor.authorCarrillo, Fatima
dc.contributor.authorHartmann, Christian J
dc.contributor.authorGroiss, Stefan Jun
dc.contributor.authorGlaser, Martin
dc.contributor.authorDefresne, Florence
dc.contributor.authorKarst, Edward
dc.contributor.authorCheeran, Binith
dc.contributor.authorVesper, Jan
dc.contributor.authorPROGRESS Study Investigators
dc.date.accessioned2023-02-09T11:39:02Z
dc.date.available2023-02-09T11:39:02Z
dc.date.issued2022-02-02
dc.description.abstractPublished reports on directional deep brain stimulation (DBS) have been limited to small, single-center investigations. Therapeutic window (TW) is used to describe the range of stimulation amplitudes achieving symptom relief without side effects. This crossover study performed a randomized double-blind assessment of TW for directional and omnidirectional DBS in a large cohort of patients implanted with a DBS system in the subthalamic nucleus for Parkinson's disease. Participants received omnidirectional stimulation for the first three months after initial study programming, followed by directional DBS for the following three months. The primary endpoint was a double-blind, randomized evaluation of TW for directional vs omnidirectional stimulation at three months after initial study programming. Additional data recorded at three- and six-month follow-ups included stimulation preference, therapeutic current strength, Unified Parkinson's Disease Rating Scale (UPDRS) part III motor score, and quality of life. The study enrolled 234 subjects (62 ± 8 years, 33% female). TW was wider using directional stimulation in 183 of 202 subjects (90.6%). The mean increase in TW with directional stimulation was 41% (2.98 ± 1.38 mA, compared to 2.11 ± 1.33 mA for omnidirectional). UPDRS part III motor score on medication improved 42.4% at three months (after three months of omnidirectional stimulation) and 43.3% at six months (after three months of directional stimulation) with stimulation on, compared to stimulation off. After six months, 52.8% of subjects blinded to stimulation type (102/193) preferred the period with directional stimulation, and 25.9% (50/193) preferred the omnidirectional period. The directional period was preferred by 58.5% of clinicians (113/193) vs 21.2% (41/193) who preferred the omnidirectional period. Directional stimulation yielded a wider TW compared to omnidirectional stimulation and was preferred by blinded subjects and clinicians.
dc.identifier.doi10.1111/ner.13407
dc.identifier.essn1525-1403
dc.identifier.pmid34047410
dc.identifier.unpaywallURLhttp://www.neuromodulationjournal.org/article/S1094715921064230/pdf
dc.identifier.urihttp://hdl.handle.net/10668/17847
dc.issue.number6
dc.journal.titleNeuromodulation : journal of the International Neuromodulation Society
dc.journal.titleabbreviationNeuromodulation
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number817-828
dc.pubmedtypeJournal Article
dc.pubmedtypeRandomized Controlled Trial
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectDeep brain stimulation
dc.subjectParkinson's disease
dc.subjectdirectional programming
dc.subjecttherapeutic window
dc.subject.meshCross-Over Studies
dc.subject.meshDeep Brain Stimulation
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshParkinson Disease
dc.subject.meshQuality of Life
dc.subject.meshTreatment Outcome
dc.titleDirectional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number25
dspace.entity.typePublication

Files